IRONWOOD PHARMACEUTICALS INC IRWD
Nasdaq · XNAS · stock · Pharmaceutical Preparations
Chart by TradingView
4/9
Piotroski F — financial health
-11.97
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Financials (annual, from 10-K)
| FY | Revenue | Net income | Gross profit | Free cash flow | Equity |
|---|---|---|---|---|---|
| 2025 | $296.2M | $24.0M | — | $127.0M | -$261.8M |
| 2024 | $351.4M | $880,000 | — | $103.4M | -$301.3M |
| 2023 | $442.7M | -$1.0B | — | $183.2M | -$346.3M |
| 2022 | $410.6M | $175.1M | — | $273.6M | $652.4M |
| 2021 | $413.8M | $528.4M | — | $261.6M | $605.9M |
| 2020 | $389.5M | $106.2M | — | $167.0M | $62.6M |
Recent insider activity (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| Shepard Jay | director | 2026-06-16 | Grant | 63,481 | — |
| Kessler Marla L | director | 2026-06-16 | Grant | 63,481 | — |
| Currie Mark G | director | 2026-06-16 | Grant | 63,481 | — |
| Duane Jon R | director | 2026-06-16 | Grant | 63,481 | — |
| DENNER ALEXANDER J | director | 2026-06-16 | Grant | 63,481 | — |
| McHugh Julie | director | 2026-06-16 | Grant | 63,481 | — |
| McHugh Julie | director | 2026-06-16 | Sell | 21,571 | $3.73 |
| Moukheibir Catherine | director | 2026-06-16 | Grant | 63,481 | — |
Why these scores methodology →
Piotroski F-score: 4/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: -11.97 (distress)
- Working capital / assets 0.081
- Retained earnings / assets -4.217
- EBIT / assets 0.248
- Equity / liabilities -0.397
Source: SEC EDGAR filings · CIK 0001446847 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.